Efficacy and safety of faecal microbiota transplantation (FMT) in recurrent Clostridioides difficile infection: results of a single-centre retrospective study
Open Access
- 1 January 2025
- journal article
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 20 (3) , 330-334
Abstract
Introduction Studies have indicated the high effectiveness of faecal microbiota transplantation (FMT) in the treatment of recurrent Clostridioides difficile infection (rCDI). However, there is still a lack of data from different subpopulations regarding FMT and the factors related to it. Aim...Keywords
This publication has 28 references indexed in Scilit:
- European consensus conference on faecal microbiota transplantation in clinical practiceGut, 2017
- Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile InfectionAnnals of Internal Medicine, 2016
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfectionJAMA, 2016
- Fecal microbiota transplantation for the treatment of Clostridium difficile infectionJournal of Hospital Medicine, 2015
- Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infectionAlimentary Pharmacology & Therapeutics, 2015
- Burden ofClostridium difficileInfection in the United StatesNew England Journal of Medicine, 2015
- Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk FactorsPLOS ONE, 2015
- Intestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile InfectionDigestive Diseases and Sciences, 2014
- A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An UpdateCNS & Neurological Disorders - Drug Targets, 2014
- Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot StudyClinical Infectious Diseases, 2014